Content Status
Type
Linked Node
Follow-up Monitoring of DR-TB Patients
Learning ObjectivesFollow-up Monitoring of DR-TB Patients
H5Content
Content
The following points should be covered in follow-up monitoring of Drug-resistant TB (DR-TB) patients:
- Monitor DR-TB treatment progress and disease response.
- Monitor bacteriological and radiological improvements in DR-TB treatment.
- Identify derangements in bio-chemical results and on Electrocardiogram (ECG) which are indicative of systemic disorders that could result in drug-induced adverse events, or comorbidities that may require timely interventions to address and improve the probability of treatment success, survival and quality of life.
- Follow-up monitoring to be done periodically based on the type of TB/ severity of disease/ type of regimen used, etc.
Components of Follow-up Monitoring
- Clinical monitoring
- Follow-up evaluations
Resources
- Guidelines for Programmatic Management of Drug-resistant Tuberculosis in India, March 2021.
- WHO Consolidated Guidelines on Tuberculosis: Module 4 - Treatment: Drug-resistant TB Treatment, 2020.
Kindly provide your valuable feedback on the page to the link provided HERE
LMS Page Link
Content Creator
Reviewer
Target Audience
- Log in to post comments